SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-22-019217
Filing Date
2022-04-11
Accepted
2022-04-11 16:40:47
Documents
25
Period of Report
2022-04-05
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.01: Completion of Acquisition or Disposition of Assets
Item 3.02: Unregistered Sales of Equity Securities
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.01: Changes in Control of Registrant
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 5.05: Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
Item 5.06: Change in Shell Company Status
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea158227-8k_moonlake.htm   iXBRL 8-K 246371
2 MEMORANDUM AND ARTICLES OF ASSOCIATION OF MOONLAKE IMMUNOTHERAPEUTICS ea158227ex3-1_moonlake.htm EX-3.1 383825
3 AMENDED AND RESTATED SHAREHOLDERS' AGREEMENT, DATED AS OF APRIL 5, 2022, BY AND ea158227ex10-2_moonlake.htm EX-10.2 440134
4 AMENDED AND RESTATED REGISTRATION RIGHTS AGREEMENT, DATED AS OF APRIL 5, 2022, B ea158227ex10-5_moonlake.htm EX-10.5 227373
5 FORM OF SUBSCRIPTION AGREEMENT ea158227ex10-7_moonlake.htm EX-10.7 167061
6 MOONLAKE IMMUNOTHERAPEUTICS 2022 EQUITY INCENTIVE PLAN ea158227ex10-8_moonlake.htm EX-10.8 135914
7 FORM OF NON-EMPLOYEE DIRECTOR STOCK OPTION AGREEMENT ea158227ex10-33_moonlake.htm EX-10.33 30989
8 CODE OF BUSINESS CONDUCT AND ETHICS ea158227ex14-1_moonlake.htm EX-14.1 60874
9 SUBSIDIARIES OF MOONLAKE IMMUNOTHERAPEUTICS ea158227ex21-1_moonlake.htm EX-21.1 1210
10 PRESS RELEASE ISSUED BY MOONLAKE IMMUNOTHERAPEUTICS ON APRIL 5, 2022 ea158227ex99-1_moonlake.htm EX-99.1 16461
11 MOONLAKE IMMUNOTHERAPEUTICS UNAUDITED PRO FORMA CONDENSED COMBINED BALANCE SHEET ea158227ex99-2_moonlake.htm EX-99.2 240904
12 GRAPHIC ex14-1_001.jpg GRAPHIC 6801
13 GRAPHIC ex99-1_001.jpg GRAPHIC 3459
14 GRAPHIC ex99-1_002.jpg GRAPHIC 2795
  Complete submission text file 0001213900-22-019217.txt   2462253

Data Files

Seq Description Document Type Size
15 XBRL SCHEMA FILE hlxa-20220405.xsd EX-101.SCH 3033
16 XBRL LABEL FILE hlxa-20220405_lab.xml EX-101.LAB 34476
17 XBRL PRESENTATION FILE hlxa-20220405_pre.xml EX-101.PRE 22595
19 EXTRACTED XBRL INSTANCE DOCUMENT ea158227-8k_moonlake_htm.xml XML 3727
Mailing Address DORFSTRASSE 29 ZUG V8 6300
Business Address DORFSTRASSE 29 ZUG V8 6300 41 41 510 8022
MoonLake Immunotherapeutics (Filer) CIK: 0001821586 (see all company filings)

IRS No.: 000000000 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39630 | Film No.: 22820096
SIC: 2834 Pharmaceutical Preparations